05:58 PM EDT, 05/29/2024 (MT Newswires) -- Zimmer Biomet Holdings ( ZBH ) said Wednesday it is targeting mid-single-digit percentage consolidated revenue compound annual growth rate on constant currency basis from 2024 through 2027.

The company also expects adjusted earnings per share growth of at least 1.5 times the growth of its revenue during this period. The so-called long-range plan also calls for free cash flow growing at least 100 basis points faster than adjusted EPS.

Additionally, Zimmer board approved a new stock repurchase program of up to $2 billion of common shares.

Price: 120.40, Change: +0.22, Percent Change: +0.18